Pharmacological treatment of patients with HFrEF: is it really optimized in case of CRT and/or ICD implantation?

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Professor Damien Logeart

Hospital Lariboisiere, Paris (France)

8 More presentations in this session

Presentation thumbnail

Evolution of level of evidence c recommendations in european society of cardiology clinical practice guidelines on heart failure

Doctor M. Trindade (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Therapy treatment, adherence and persistence in chronic heart failure patients: a populaion study, from 2005 to TO 2012 in Lombardy

Doctor S. Scalvini (Lumezzane, IT)

Abstract Slides

Presentation thumbnail

The myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Doctor N. Pavo (Vienna, AT)

Presentation thumbnail

All cause mortality outcomes of various types of stem cell therapies in patients with dilated cardiomyopathy: an updated meta analysis and systematic review

Doctor Y. Illahi (Multan, PK)

Abstract Slides

Presentation thumbnail

The impact of highest doses of ACEi/ARB therapy on mortality of patients suffering from heart failure with reduced ejection fraction: a long-term follow-up, propensity-matched cohort study

Doctor B. Muk (Budapest, HU)

Access the full session

Session thumbnail

Poster Session 2 - Treatment of heart failure

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

Expert panel discussion and Q&A

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources